Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05888571

Pre-pectoral Breast Reconstruction With or Without Mesh

To explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that when TiLOOP Mesh is not used.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Tianjin Medical University Cancer Institute and Hospital

Tianjin, Tianjin Municipality, 300060, China

Location status: Recruiting

Location contact

Chunyong Han, MD.

CONTACT

[email protected]

+86-22-23340123 ext. 1174

Jian Yin, MD.

PRINCIPAL_INVESTIGATOR

About this study

The clinical study aims to explore the efficacy and safety that occur after immediate prepectoral breast reconstruction when TiLOOP Mesh is used compared to that not using TiLOOP Mesh.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult women aged 18-65 years who plan to undergo unilateral or bilateral immediate prepectoral prothesis breast reconstruction;
  • SSM or NSM or Skin-Reducing Mastectomy for breast cancer patients or prophylactic mastectomy;
  • Tissue expander size =<800cc, implant size =<600cc;
  • The blood perfusion of breast skin flap was well;
  • Do not smoking in the last 4 weeks or more
  • Patients with normal expectations and mental health for breast reconstruction;
  • Signed consent to participate

Exclusion criteria

  • Poor perfusion of breast mastectomy flap;
  • II stage breast reconstruction patients;
  • History of chest radiotherapy;
  • BMI greater than 35;
  • Patients who have not quit smoking within the last 4 weeks;

Treatment and study plan

prepectoral breast reconstruction

Procedure

Patients receive immediate prepectoral breast reconstruction

Tiloop Mesh implantation

Procedure

Patients receive immediate prepectoral breast reconstruction with Tiloop Mesh

Primary outcomes

  1. Major Complication Rates

    Time frame: up to 12 months after surgery

    The rate of major complications in the two groups

  2. Patient Breast-Q questionnaire

    Time frame: up to 12 months after surgery

    We use the Breast-Q questionnaire to evaluate patients' satisfaction via the reconstruction module of BREAST-Q.

Secondary outcomes

  1. Minor Complication Rates

    Time frame: up to 12 months after surgery

    The rate of minor complications in the two groups

  2. Rates of capsule contracture

    Time frame: up to 24 months after surgery

    The rates of capsule contracture in the two groups

  3. The rate of surgical revision of reconstructed breasts

    Time frame: up to 12 months after surgery

    To record the rate of surgical revision events of the reconstructed breasts

  4. The rate of implant or tissue expander removal

    Time frame: up to 12 months after surgery

    The rate of implant or tissue expander removal in the two groups

Study contacts

Contact information is provided by the study sponsor or research team.

Chunyong Han

CONTACT

[email protected]

+86-22-23340123 ext. 1171

Jian Yin

CONTACT

[email protected]

+86-22-23340123 ext. 1171

Sponsors and collaborators

Lead sponsor

Tianjin Medical University Cancer Institute and Hospital

Other

Registry information

Official study title

A Randomized Controlled Trial of Prepectoral Breast Reconstruction With and Without Mesh

Important dates

Study start
2023
Primary completion
2026
Study completion
2026
First posted
Jun 5, 2023
Registry last updated
Jan 31, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.